Tyra Biosciences Inc. (TYRA) Live Share Price, Invest From India

Tyra Biosciences Inc. Stock Performance

as on July 2, 2026 at 2:16 pm IST

Day's Low
Day's High
$29.27
Day's Price Range
$32.30
$29.41
0.48%
Downside
9.83%
Upside
52 Week's Low
52 Week's High
$9.47
52-Week Price Range
$40.65
$29.41
67.80%
Downside
38.22%
Upside

Tyra Biosciences Inc. share price movements today

Previous Close: $31.94
Open: $32.13
Volume: 737.2K
Day's Low - High: $29.27 - $32.30
52 Week Low - High: $9.47 - $40.65

Tyra Biosciences Inc. Historical Returns

1 Month Return: + 2.62 %
3 Month Return: -25.75 %
1 Year Return: + 192.64 %
3 Year Return: + 72.7 %
5 Year Return: 0 %

Tyra Biosciences Inc. Stock Fundamentals & Key Indicators

Check Tyra Biosciences Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.8B

EPS (TTM)

-2.5507

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-142.4M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-36.87%

Tyra Biosciences Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tyra Biosciences Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Tyra Biosciences Inc.	BUY	$1.8B	NA	NA	0.00%	NA
Revolution Medicines Inc.	BUY	$39.8B	472.9%	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$40.2B	75.97%	75.83	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$126.1B	148.33%	29.5	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$65.4B	7.04%	15.22	29.65%	0.5700000000000001%

Stock Returns calculator for Tyra Biosciences Inc. Stock including INR - Dollar returns

The Tyra Biosciences Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Tyra Biosciences Inc. investment value today

Current value as on today

₹3,25,504

Returns

₹2,25,504

(+225.5%)

Returns from Tyra Biosciences Inc. Stock

₹1,92,637 (+192.64%)

Dollar Impact

₹32,867 (+32.87%)

Analyst Recommendation on Tyra Biosciences Inc. Stock

Based on 12 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for Tyra Biosciences Inc.. Average target price of $51.97

Tyra Biosciences Inc. Share Price Target

Get share price movements and forecasts by analysts on Tyra Biosciences Inc..

What analysts predicted

43.41%UPSIDE

Target Price

$51.97

Current Price

$29.41

Analyzed by

12 Analysts

Target

$51.97

Tyra Biosciences Inc. target price $51.97, a slight upside of 43.41% compared to current price of $29.41. According to 12 analysts rating.

Indian Investors' Interest in Tyra Biosciences Inc. Stock

Search interest for Tyra Biosciences Inc. Stock has increased by 12% in the last 30 days, reflecting an upward trend in search activity.

Time period: June 2, 2026 to July 2, 2026

Change:12% versus previous 30 day period

Tyra Biosciences Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	0	-	-	-	0	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	-	0	0
Operating Income	-25	-22	-23	-28	-29	-31	-31	-32	-36	-41
EBITDA	-22	-18	-18	-23	-25	-28	-27	-29	-33	-39
Interest Expense	2	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-22	-18	-18	-24	-25	-28	-28	-29	-33	-39
Income Tax Expense	8	0	-	-	-	-	-	-	-	-
Net Income	-22	-18	-18	-24	-25	-28	-28	-29	-33	-39
Net Profit Margin	-4547.81%	0.00%	0.00%	0.00%	-5155.44%	0.00%	0.00%	0.00%	0.00%	0.00%

Tyra Biosciences Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0
Operating Income	-3	-9	-26	-58	-79	-104	-132
EBITDA	-3	-9	-26	-58	-68	-85	-119
Interest Expense	0	0	0	0	-	-	-
Depreciation	0	0	0	0	0	0	0
Income Before Tax	-4	-9	-26	-55	-69	-86	-119
Income Tax Expense	0	0	0	-3	-	-	-
Net Income	-4	-9	-26	-51	-69	-86	-119
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Tyra Biosciences Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-18	-18	-24	-25	-28	-28	-29	-33	-39
Operating Cash Flow	-22	-10	-17	-19	-25	-23	-22	-23	-32
Investing Cash Flow	18	-144	21	6	32	20	-14	34	-120
Financing Cash Flow	200	0	0	0	2	0	0	4	160
Change in Cash	196	-154	4	-11	8	-2	-36	15	7

Tyra Biosciences Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-9	-26	-55	-69	-86	-119
Operating Cash Flow	-7	-23	-50	-50	-69	-95
Investing Cash Flow	0	0	0	-144	-98	72
Financing Cash Flow	23	311	0	1	202	8
Change in Cash	15	286	-50	-193	33	-14

Global Institutional Holdings in Tyra Biosciences Inc.

Funds	Holdings
Vanguard Capital Management, LLC	1.89%
Kynam Capital Management, LP	2.63%
Nextech Invest, Ltd.	6.82%
COMMODORE CAPITAL LP	4.16%
Geode Capital Management, LLC	1.11%

See all

Insights on Tyra Biosciences Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 year, TYRA stock has moved up by 192.6%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 601.0% return, outperforming this stock by 528.3%
NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 404.2% return, outperforming this stock by 211.6%

About Tyra Biosciences Inc.

Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is FGFR3, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in clinical trial for intrahepatic cholangiocarcinoma; and TYRA-430 for the treatment of hepatocellular carcinoma. Tyra Biosciences, Inc. was incorporated in 2018 and is headquartered in Carlsbad, California.

Organisation	Tyra Biosciences Inc.
Headquarters	2656 State Street, Carlsbad, CA, United States, 92008
Industry	Biotechnology
CEO	Dr. Todd Harris Ph.D.
E-voting on shares	Click here to vote

Key Management of Tyra Biosciences Inc.

Name	Title
Dr. Douglas Warner M.D.	Chief Medical Officer
Dr. Ronald V. Swanson Ph.D.	Chief Scientific Officer
Ms. Sarah Honig	Senior VP of Corporate Development & Strategy
Mr. Bhavesh Ashar M.B.A.	Chief Operating Officer
Mr. Daniel Bensen	Co-Founder & Chief Discovery Officer
Mr. Alan Fuhrman CPA	Chief Financial Officer
Ms. Julia Rueb	VP of Finance & Principal Accounting Officer
Dr. Robert L. Hudkins Ph.D.	Chief Technology Officer
Mr. Ali D. Fawaz J.D.	General Counsel & Secretary
Dr. Todd Harris Ph.D.	Co-Founder, CEO, President & Director

FAQs

What is Tyra Biosciences Inc. share price today?

Tyra Biosciences Inc. share price today is $29.41 as on July 2, 2026 at 8:46 am IST at the close of the market. Tyra Biosciences Inc. share today touched a day high of $32.3 and a low of $29.27.

What is the 52 week high and 52 week low for Tyra Biosciences Inc. share?

Tyra Biosciences Inc. share touched a 52 week high of $40.65 on April 1, 2026 and a 52 week low of $9.47 on July 7, 2025. Tyra Biosciences Inc. stock price today i.e. July 2, 2026 at 8:46 am IST is closed at $29.41,which is 27.65% down from its 52 week high and 210.56% up from its 52 week low.

What is Tyra Biosciences Inc.'s market capitalisation today?

Tyra Biosciences Inc. market capitalisation is $0.00T as on July 2, 2026 at 8:46 am IST.

How to invest in Tyra Biosciences Inc. Stock (TYRA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Tyra Biosciences Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tyra Biosciences Inc. Shares that will get you 0.0510 shares as per Tyra Biosciences Inc. share price of $29.41 per share as on July 2, 2026 at 8:46 am IST.

What is the minimum amount required to buy Tyra Biosciences Inc. Stock (TYRA) from India?

Indian investors can start investing in Tyra Biosciences Inc. (TYRA) shares with as little as ₹95.2475 or $1 (as of July 2, 2026 at 10:43 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹952.48 in Tyra Biosciences Inc. stock (as per the Rupee-Dollar exchange rate as on July 2, 2026 at 10:43 am IST). Based on Tyra Biosciences Inc. share’s latest price of $29.41 as on July 2, 2026 at 8:46 am IST, you will get 0.3400 shares of Tyra Biosciences Inc.. Learn more about fractional shares .